Quotes 5-day view Delayed Toronto Stock Exchange
10/16/2020
10/19/2020
10/20/2020
10/21/2020
10/22/2020
Date
0.135(c)
0.135(c)
0.13(c)
0.125(c)
0.13 Last
375 500
39 920
53 950
163 678
34 505 Volume
+8.00% 0.00% -3.70% -3.85% +4.00% Change
Sales 2020
-
-
-
Net income 2020
-6,80 M -5,16 M -5,16 M
Net Debt 2020
-
-
-
P/E ratio 2020
-6,33x
Yield 2020
-
Sales 2021
-
-
-
Net income 2021
-15,6 M -11,8 M -11,8 M
Net Debt 2021
-
-
-
P/E ratio 2021
-3,17x
Yield 2021
-
Capitalization
36,2 M 27,6 M 27,5 M
Capi. / Sales 2020
-
Capi. / Sales 2021
-
Nbr of Employees
-
Free-Float
90,1%
ProMIS Neurosciences Inc, formerly Amorfix Life Sciences Ltd, is a Canada-based development-stage biotech company. The Company discovers and develops precision therapeutics with companion diagnostics for early detection and treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The assays are developed using its technologies, Epitope Protection and...
All news about PROMIS NEUROSCIENCES, INC.
News in other languages on PROMIS NEUROSCIENCES, INC.
- No features available -
Chart PROMIS NEUROSCIENCES, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PROMIS NEUROSCIENCES, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
-
Number of Analysts
1
Average target price
4,16 $
Last Close Price
0,09 $
Spread / Highest target
4 281%
Spread / Average Target
4 281%
Spread / Lowest Target
4 281%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
